Zhengye Biotechnology Holding (ZYBT) Market Capitalization (2025)
Zhengye Biotechnology Holding's (ZYBT) quarterly Market Capitalization came in at $54.5 million in Q4 2025, down 80.01% quarter-over-quarter from $272.6 million in Q2 2025.
Powered by 
Analysis
Zhengye Biotechnology Holding (ZYBT) Market Capitalization (2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Market Capitalization for 1 consecutive years, with $54.5 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Market Capitalization changed N/A year-over-year to $54.5 million in Q4 2025; TTM through Dec 2025 was $54.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.5 million, changed N/A from the prior year.
- Market Capitalization was $54.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $272.6 million in the prior quarter.
- Over five years, Market Capitalization peaked at $272.6 million in Q2 2025 and troughed at $54.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |